| Literature DB >> 32140557 |
Jeffrey K Lee1,2,3, Trilokesh D Kidambi4, Tonya Kaltenbach5,3, Yasser M Bhat6, Amandeep Shergill5,3, Kenneth R McQuaid5,3, Jonathan P Terdiman3, Roy M Soetikno5,7.
Abstract
Background and study aims Endoscopic mucosal resection (EMR) is standard treatment for large colorectal polyps. However, it is a specialized technique with limited data on the effectiveness of training methods to acquire this skill. The aim of this study was to evaluate the impact of observational training on EMR outcomes and competency in an early-stage endoscopist. Patients and methods A single endoscopist completed comprehensive EMR training, which included knowledge acquisition and direct observation of EMR cases, and proctored supervision, during the third year of gastroenterology fellowship. After training, EMR was independently attempted on 142 consecutive, large (i. e., ≥ 20 mm), non-pedunculated colorectal polyps between July 2014 and December 2017 (mean age 61.7 years; mean polyp size 30.4 mm; en-bloc resection 55 %). Surveillance colonoscopy for evaluation of residual neoplasia was available for 86 % of the cases. Three primary outcomes were evaluated: endoscopic assessment of complete resection, rate of adverse events (AEs), and rate of residual neoplasia on surveillance colonoscopy. Results Complete endoscopic resection was achieved in 93 % of cases, the rates of AEs and residual neoplasia were 7.8 % and 7.3 %, respectively. The rate of complete resection remained stable (at 85 % or greater) with increasing experience while rates of AEs and residual neoplasia peaked and decreased after 60 cases. Conclusions An early-stage endoscopist can acquire the skills to perform effective EMR after completing observational training. At least 60 independent EMRs for large colorectal polyps were required to achieve a plateau for clinically meaningful outcomes.Entities:
Year: 2020 PMID: 32140557 PMCID: PMC7055616 DOI: 10.1055/a-1107-2711
Source DB: PubMed Journal: Endosc Int Open ISSN: 2196-9736
Fig. 1 Flow diagram for cohort selection.
Baseline patient information.
| All patients (n = 142) | |
| Mean age (years) | 61.7 (range 26–87; SD 10.3) |
| Male | 72 (50.7) |
| Race/ethnicity | |
White | 98 (69.0) |
Hispanic | 19 (13.4) |
Black | 5 (3.5) |
Asian | 20 (14.1) |
| ASA class | |
1 | 38 (26.8) |
2 | 71 (50.0) |
3 | 31 (21.8) |
4 | 2 (1.4) |
| Moderate sedation | 100 (70.4) |
| Anesthesiologist administered sedation | 42 (29.6) |
| Mean body mass index | 27.6 (SD 5.6) |
| Aspirin use | 39 (27.5) |
|
Antithrombotic use
| 11 (7.8) |
ASA, American Society of Anesthesia classification; EMR, endoscopic mucosal resection; SD, standard deviation Unless otherwise specified, values listed as number [n, (%)].
Clopidogrel, warfarin, direct oral anticoagulants
EMR information.
| All patients (n = 142) | |
| Polyp location | |
| Cecum | 13 (9.2) |
| Ascending colon | 87 (61.3) |
| Hepatic flexure | 7 (4.9) |
| Transverse colon | 7 (4.9) |
| Splenic flexure | 1 (0.7) |
| Descending colon | 4 (2.8) |
| Sigmoid colon | 11 (7.8) |
| Rectum | 4 (2.8) |
| Ileocecal valve | 6 (4.2) |
| Appendiceal orifice | 2 (1.4) |
| Mean polyp size (mm) | 30.4 (SD 15.5) |
| Median polyp size (mm) | 25.0 (range 20–100) |
| Paris classification | |
Is | 39 (27.5) |
Is + IIa | 18 (12.7) |
IIa | 82 (57.8) |
IIb | 1 (0.7) |
IIc | 1 (0.7) |
IIa + IIc | 1 (0.7) |
| Referral for EMR | 78 (54.9) |
| Prior biopsy of lesion | 64 (45.1) |
| Prior snare of lesion | 10 (7.0) |
| En bloc resection | 78 (54.9) |
| Prophylactic clip placement | 125 (88.0) |
| Pathology | |
High-grade dysplasia | 13 (9.2) |
Villous adenoma | 1 (0.7) |
Tubulovillous adenoma | 18 (12.7) |
Tubular adenoma | 52 (36.6) |
Sessile serrated adenoma | 54 (38.0) |
Traditional serrated adenoma | 2 (1.4) |
Adenocarcinoma | 2 (1.4) |
EMR, endoscopic mucosal resection; SD, standard deviation
EMR outcomes.
| Summary | |
| Endoscopic assessment of complete resection | 132/142 (93.0 %) |
| Adverse event | 11/142 (7.8 %) |
| Perforation | 1/142 (0.7 %) |
| Early bleed | 2/142 (1.4 %) |
| Delayed bleed | 6/142 (4.2 %) |
| Post-polypectomy syndrome | 2/142 (1.4 %) |
| Residual neoplasia on follow-up | 9/123 (7.3 %) |
EMR, endoscopic mucosal resection
Fig. 2 EMR outcomes by increasing experience . *prior manipulation includes prior biopsy, snare attempt, and/or injection.